Mark Paterson
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Cardiac Ischemia and Reperfusion 2
- Co-authors
- Alison J. Kriegel (4 shared papers)Zeljko J. Bosnjak (4 shared papers)Zhi‐Dong Ge (4 shared papers)David C. Warltier (3 shared papers)Judy R. Kersten (3 shared papers)Aron M. Geurts (1 shared paper)Yanan Liu (2 shared papers)Juan Fang (2 shared papers)
- Journals
- Circulation Heart Failure (1 paper)JCI Insight (1 paper)Physiological Genomics (1 paper)Anesthesiology (1 paper)Kidney International (1 paper)
- Partner nations
- United StatesNetherlandsHong Kong
In The Last Decade
Mark Paterson
9 papers receiving 330 citations
Peers
Comparison fields: 5 of 63
- Cancer Research 110
- Developmental Neuroscience 20
- Cardiology and Cardiovascular Medicine 54
- Molecular Biology 152
- Pathology and Forensic Medicine 32
Countries citing papers authored by Mark Paterson
This map shows the geographic impact of Mark Paterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Paterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Paterson more than expected).
Fields of papers citing papers by Mark Paterson
This network shows the impact of papers produced by Mark Paterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Paterson. The network helps show where Mark Paterson may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Paterson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 119 | |
| 2 | 2015 | 56 | |
| 3 | 2016 | 51 | |
| 4 | 2018 | 30 | |
| 5 | 2019 | 30 | |
| 6 | 2016 | 24 | |
| 7 | 2022 | 15 | |
| 8 | 2020 | 3 | |
| 9 | The phakomatoses: recent advances in genetics. | 1997 | 3 |
About Mark Paterson
Mark Paterson is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine, Cancer Research and Neurology, having authored 9 papers that have together received 331 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (2 papers), Cardiac Ischemia and Reperfusion (2 papers), Plant Molecular Biology Research (1 paper), Nitric Oxide and Endothelin Effects (1 paper), Cardiac electrophysiology and arrhythmias (1 paper), Neurofibromatosis and Schwannoma Cases (1 paper), Chromosomal and Genetic Variations (1 paper) and Cardiovascular Function and Risk Factors (1 paper). The work is most often cited by research in Cancer Research (110 citations), Developmental Neuroscience (20 citations), Cardiology and Cardiovascular Medicine (54 citations), Molecular Biology (152 citations) and Pathology and Forensic Medicine (32 citations). Mark Paterson has collaborated with scholars based in United States, Netherlands and Hong Kong. Frequent co-authors include Alison J. Kriegel, Zeljko J. Bosnjak, Zhi‐Dong Ge, David C. Warltier, Judy R. Kersten, Aron M. Geurts, Yanan Liu, Juan Fang, Shigang Qiao and Thorsten M. Leucker. Their work appears in journals such as Circulation Heart Failure, JCI Insight, Physiological Genomics, Anesthesiology and Kidney International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.